Progressive pancreatic islet hyperplasia in the islet-targeted, parathyroid hormone-related protein-overexpressing mouse.
PTH-related protein (PTHrP) is a paracrine/autocrine factor produced in most cell types in the body. Its functions include the regulation of cell cycle, of differentiation, of apoptosis, and of developmental events. One of the cells which produces PTHrP is the pancreatic beta cell. We have previously described a transgenic mouse model of targeted overexpression of PTHrP in the beta cell, the RIP-PTHrP mouse. These studies showed that PTHrP overexpression markedly increased islet mass and insulin secretion and resulted in hypoglycemia. Those studies were limited to RIP-PTHrP mice of 8-12 weeks of age. In the current report, we demonstrate that PTHrP overexpression induces a progressive increase in islet mass over the life of the RIP-PTHrP mouse, and that, in contrast to some other models of targeted PTHrP overexpression, the phenotype is not developmental, but occurs postnatally. The marked increase in islet mass is not associated with a measurable increase in beta cell replication rates. A further slowing in the normally low islet apoptosis rate could not be demonstrated in the RIP-PTHrP islet. Thus, the marked increase in islet mass in the RIP-PTHrP mouse is unexplained in mechanistic terms. Finally, RIP-PTHrP mice are resistant to the diabetogenic effects of streptozotocin. The mechanisms responsible for the increase in islet mass in the RIP-PTHrP mouse likely lie in either very subtle changes in islet turnover or in early steps in islet differentiation and development. The ability of PTHrP to increase islet mass and function, as well as its ability to attenuate the diabetogenic effects of streptozotocin, indicate that further study of PTHrP on islet development and function are important and may lead to therapeutic strategies in diabetes mellitus.
Yale University School of Medicine, New Haven, Connecticut 06520, USA.
S E
SE
Porter
R L
RL
Sorenson
P
P
Dann
A
A
Garcia-Ocana
A F
AF
Stewart
R C
RC
Vasavada
D000818:Animals; D000831:Animals, Newborn / Q000235:genetics / Q000502:physiology; D002118:Calcium / Q000097:blood; D018450:Disease Progression; D005260:Female; D015870:Gene Expression / Q000502:physiology; D018390:Gene Targeting; D006946:Hyperinsulinism / Q000235:genetics; D006965:Hyperplasia; D007003:Hypoglycemia / Q000235:genetics; D007515:Islets of Langerhans / Q000473:pathology*; D007743:Labor, Obstetric / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics; D044162:Parathyroid Hormone-Related Protein; D011247:Pregnancy; D011506:Proteins / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D013311:Streptozocin / Q000494:pharmacology
D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D012333:RNA, Messenger; D013311:Streptozocin; D002118:Calcium